Insulet
PODD
₹21,079
Share price
-1.57%
Change (1 day)
53.16%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
EPS for Insulet (PODD)
EPS in 2023 (TTM): ₹142.16
According to Insulet's latest financial reports the company's current EPS (TTM) is ₹146.90. In 2022 the company made an earnings per share (EPS) of ₹5.98 a decrease over its 2021 EPS that were of ₹19.64.
EPS history for Insulet from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | ₹142.16 | 2277.84% |
| 2022 | ₹5.98 | -69.57% |
| 2021 | ₹19.64 | 109.09% |
| 2020 | ₹9.39 | -38.89% |
| 2019 | ₹15.37 | 200% |
| 2018 | ₹5.12 | -113.04% |
| 2017 | -₹39.29 | -9.8% |
| 2016 | -₹43.56 | -60.77% |
| 2015 | -₹111.03 | 39.78% |
| 2014 | -₹79.43 | 12.05% |
| 2013 | -₹70.89 | -23.15% |
| 2012 | -₹92.24 | 10.2% |
| 2011 | -₹83.70 | -36.36% |
| 2010 | -₹131.53 | -36.63% |
| 2009 | -₹207.54 | -29.36% |
| 2008 | -₹293.81 | -86.74% |
| 2007 | -₹2,216 | -64.04% |
| 2006 | -₹6,162 | 122.23% |
| 2005 | -₹2,773 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -₹172.53 | -217.44% | 🇺🇸 USA |
 | -₹275.87 | -287.79% | 🇺🇸 USA |
 | ₹83.70 | -43.02% | 🇺🇸 USA |
 | ₹1,203 | 718.91% | 🇺🇸 USA |
 | ₹253.85 | 72.80% | 🇺🇸 USA |
 | ₹232.31 | 58.14% | 🇮🇪 Ireland |
 | ₹463.71 | 215.66% | 🇺🇸 USA |